Difference between revisions of "Template:Adrenergic receptor modulators"
Jump to navigation
Jump to search
blackwiki>Medgirl131 |
blackwiki>Medgirl131 |
||
| Line 165: | Line 165: | ||
: [[Romifidine]] | : [[Romifidine]] | ||
: [[Talipexole]] | : [[Talipexole]] | ||
| + | : [[Tasipimidine]] | ||
: [[Tetrahydrozoline]] | : [[Tetrahydrozoline]] | ||
: [[Tiamenidine]] | : [[Tiamenidine]] | ||
| Line 170: | Line 171: | ||
: [[Tolonidine]] | : [[Tolonidine]] | ||
: [[Urapidil]] | : [[Urapidil]] | ||
| + | : [[Vatinoxan]] | ||
: [[XP21279]]<!--Prodrug--> | : [[XP21279]]<!--Prodrug--> | ||
: [[Xylazine]] | : [[Xylazine]] | ||
Revision as of 00:11, 1 September 2017
File:Test Template Info-Icon - Version (2).svg Template documentation
Initial visibility: currently defaults to autocollapse
To set this template's initial visibility, the |state= parameter may be used:
|state=collapsed:{{Adrenergic receptor modulators|state=collapsed}}to show the template collapsed, i.e., hidden apart from its title bar|state=expanded:{{Adrenergic receptor modulators|state=expanded}}to show the template expanded, i.e., fully visible|state=autocollapse:{{Adrenergic receptor modulators|state=autocollapse}}
If the |state= parameter in the template on this page is not set, the template's initial visibility is taken from the |default= parameter in the Collapsible option template. For the template on this page, that currently evaluates to autocollapse.
| Editors can experiment in this template's sandbox (edit | diff) and testcases (create) pages. Subpages of this template. |